BWCDX - LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION,USP,4903,7931,7939.

  • MSDS: BWCDX
  • Manufacturer: ABBOTT LABORATORIES DIAGNOSTICS DIV
  • Product Name: LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION,USP,4903,7931,7939.
  • National Stock Number: 6505-00-772-0157
Product Identification

Product ID:LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION,USP,4903,7931,7939.
MSDS Date:12/13/1991
FSC:6505
NIIN:00-772-0157
MSDS Number: BWCDX

Responsible Party
ABBOTT LABORATORIES, DIAGNOSTICS DIVISION
RT 43 AND 137
ABBOTT PARK, IL 60064-9078
US

Emergency Phone: 708-937-7970/800-323-9100

Info Phone: 708-937-7970/800-323-9100

Cage: 0ALT7

Contractor
ABBOTT LABORATORIES DIAGNOSTICS DIV
NORTH CHICAGO, IL 60064-9078 US

Telephone: 800-323-9100

Cage: 0ALT7

Ingredients

LIDOCAINE HYDROCHLORIDE IN AQUEOUS SOLUTION.

CAS: 73-78-9

RTECS: AN7600000


AQUEOUS SOLUTION

Hazards

LD50 LC50 Mixture:LD50=220-457MG/KG,MICE,ORAL.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:CONTAINS LIDOCAINE HYDROCHLORIDE IN
AQU SOLN.HEALTH RELATED DATA FOR PROD BASED ON LIDOCAINE
HYDROCHLORIDE CONTENT.LOC ANESTHETIC THAT PRODUCES NUMBUNESS & THAT
AFFECTS CNS & CARDIOVASCULAR SYSTEM.CAN AFFECT FETUS(FETAL HYPOXIA
OR BRADYCARDIA)IF USED DURING LABOR/DELIVERY.INFREQUENT INDICES
DELAYED HYPERSENSITIVITY RES
Explanation of Carcinogenicity:PER
MSDS:CARCINOGENICITY:NTP/IARC/OSHA/ACGIH:NOT LISTED.
Effects of Overexposure:IN CLINICAL USE PRODUCES
NUMBNESS,LIGHTHEADEDNESS,DROWS,DIZZ,RESTLESSNESS,LOSS OF
HEARING,BREATH/SWALLOWE
DYSFUNCTION,APPREHENSION,EUPHORIA,TINNITIS,ALTERED
VISION,VOMIT,SENSATION OF HOT/COLD NUMBNESS
,TWITCHING,TREMORS,STUPOR,CONVULSIONS,UNCONSC,RESP
ARREST,HYPOTENSION,BRADYCARDIA & CARDIOVASCULAR COLLAPSE.
Medical Cond Aggravated by Exposure:SENSITIVITY TO LOCAL ANESTHETICS.
PRE-EXISTING CARDIOVASCULAR OR CENTRAL NERVOUS SYSTEM DISEASE.

First Aid

First Aid:REMOVE FROM SOURCE OF EXPOSURE. SKIN/EYE CONTACT OCCURS FLUSH
W/COPIOUS AMTS OF WATER. IF IRRIT PERSISTS OR SIGNS OF TOXICITY
OCCUR SEEK MED ATTN. NO KNOWN ANTIDOTE. PROVIDE
SYMPTOMATIC/SUPPORTIVE, MO NITORING CARDIAC & RESP FUNCTION, CARE
AS NECESSARY.

Fire Fighting

Flash Point:NON-FLAMMABLE
Extinguishing Media:PER MSDS:N/A. HOWEVER USE APPROPRIATE EXTINGUISHING
MEDIA FOR SURROUNDING FIRE.
Fire Fighting Procedures:NONE.
Unusual Fire/Explosion Hazard:NONE.

Accidental Release

Spill Release Procedures:ABSORB WITH SUITABLE MATERIAL. FLUSH WITH
WATER.
Neutralizing Agent:NONE SPECIFIED BY MFG.

Handling

Handling and Storage Precautions:NONE.
Other Precautions:NONE.

Exposure Controls

Respiratory Protection:NONE REQUIRED.
Ventilation:NO SPECIAL PROVISIONS REQUIRED.
Protective Gloves:GLOVES TO MINIMIZE SKIN CONTACT.
Eye Protection:GOGGLES.
Other Protective Equipment:N/A.
Work Hygienic Practices:WASH HANDS AFTER HANDLING.
Supplemental Safety and Health

Chemical Properties

HCC:N1
Boiling Pt:B.P. Text:WATER(APRX)
Melt/Freeze Pt:M.P/F.P Text:WATER(APRX)
Spec Gravity:WATER(APPROX)
pH:3-7
Viscosity:WATER(APPROX)
Solubility in Water:AQUEOUS SOLUTION
Appearance and Odor:CLEAR LIQUID.
Percent Volatiles by Volume:NELGIG

Stability

NONE.
Stability Condition to Avoid:NONE.
Hazardous Decomposition Products:NOT DETERMINED.

Disposal

Waste Disposal Methods:DISPOSE IN ACCORDANCE WITH LOCAL, STATE AND
FEDERAL REGULATIONS. AS OF REVIEW DATE OF THIS DOCUMENT (MFG'S
MSDS) THIS CHEMICAL IS NOT AN RCRA HAZ WASTE (PER 40CFR PART 261).

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.